EDGAR Filing Documents for 0001193125-15-087416

Form 8-K - Current report:

SEC Accession No. 0001193125-15-087416

Filing Date

2015-03-11

Accepted

2015-03-11 16:30:17

Documents

Period of Report

2015-03-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d889788d8k.htm	8-K	32547
2	EX-2.1	d889788dex21.htm	EX-2.1	647413
3	EX-4.1	d889788dex41.htm	EX-4.1	63692
4	EX-4.2	d889788dex42.htm	EX-4.2	119023
5	EX-10.1	d889788dex101.htm	EX-10.1	1343378
6	EX-10.2	d889788dex102.htm	EX-10.2	54907
7	GRAPHIC	g889788ex2_1pg109a.jpg	GRAPHIC	8765
8	GRAPHIC	g889788ex2_1pg111a.jpg	GRAPHIC	9046
	Complete submission text file	0001193125-15-087416.txt		2287080

Mailing Address 490 LAPP ROAD MALVERN PA 19355

Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400

Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)